Clinical Trials Finder
Independent ClinicalTrials.gov directory
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency

ClinicalTrials.gov ID: NCT06948214

Public ClinicalTrials.gov record NCT06948214. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced May 5, 2026, 1:39 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, 12-Month, Randomized, Double Blind, Placebo-Controlled Phase 3 Efficacy and Safety Study of Daily Oral LUM-201 in Naïve-to-Treatment, Prepubertal Children With Growth Hormone Deficiency (GHD)

Study identification

NCT ID
NCT06948214
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Lumos Pharma
Industry
Enrollment
150 participants

Conditions and interventions

Interventions

  • LUM-201 Drug
  • Matched Placebo (Capsules) Other

Drug · Other

Eligibility (public fields only)

Age range
3 Years to 11 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2026
Primary completion
Nov 30, 2027
Completion
Dec 31, 2027
Last update posted
May 3, 2026

2026 – 2028

United States locations

U.S. sites
23
U.S. states
17
U.S. cities
23
Facility City State ZIP Site status
Lumos Pharma Investigational Site Birmingham Alabama 35233 Recruiting
Lumos Pharma Investigational Site Madera California 93636 Recruiting
Lumos Pharma Investigational Site Sacramento California 95821 Recruiting
Lumos Pharma Investigational Site Centennial Colorado 80112 Recruiting
Lumos Pharma Investigational Site Greenwood Village Colorado 80111 Recruiting
Lumos Pharma Investigational Site Washington D.C. District of Columbia 20010 Recruiting
Lumos Pharma Investigational Site Hollywood Florida 33021 Recruiting
Lumos Pharma Investigational Site Miami Florida 33155 Recruiting
Lumos Pharma Investigational Site Orlando Florida 32806 Recruiting
Lumos Pharma Investigational Site Tallahassee Florida 32308 Recruiting
Lumos Pharma Investigational Site Indianapolis Indiana 46202 Recruiting
Lumos Pharma Investigational Site Iowa City Iowa 52242 Recruiting
Lumos Pharma Investigational Site New Orleans Louisiana 70118 Recruiting
Lumos Pharma Investigational Site Minneapolis Minnesota 55454 Recruiting
Lumos Pharma Investigational Site Kansas City Missouri 64108 Recruiting
Lumos Pharma Investigational Site Las Vegas Nevada 89113 Recruiting
Lumos Pharma Investigational Site New Brunswick New Jersey 08901 Recruiting
Lumos Pharma Investigational Site Staten Island New York 10306 Recruiting
Lumos Pharma Investigational Site Columbia South Carolina 29203 Recruiting
Lumos Pharma Investigational Site Amarillo Texas 79106 Recruiting
Lumos Pharma Investigational Site Corpus Christi Texas 78411 Recruiting
Lumos Pharma Investigational Site Charlottesville Virginia 22908 Recruiting
Lumos Pharma Investigational Site Seattle Washington 98105 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06948214, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 3, 2026 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06948214 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →